Effect of evolocumab or ezetimibe added to moderate- or high-intensity statin therapy on LDL-C lowering in patients with hypercholesterolemia: the LAPLACE-2 randomized clinical trial.

Français
Author : 
Robinson, JG ; Nedergaard, BS ; Rogers, WJ ; Fialkow, J ; Neutel, JM ; Ramstad, D & al
Newspaper edition : 
JAMA - Année 2014 - Volume 311 - Page 1870-82 - PMID 24825642